Tinidazole
14 NDCs across 6 manufacturers|12 Generic,2 Brand
Tinidazole is used to treat amebiasis, giardiasis and bacterial vaginosis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on May 17, 2004, and the first generic was approved Apr 30, 2012. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $387K on Tinidazole across 9,278 claims for 7,323 beneficiaries.
Tinidazole is available as 14 NDCs from 6 manufacturers (12 generic, 2 brand), with NADAC prices from $1.50 to $13.01 per EA — the most expensive product costs about 8.7× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
14
12G / 2B
Manufacturers
6
competing in market
Price Spread
$1.50 – $13.01
per EA
7d Activity
avg +2.7% WoW · of 14 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Lupin Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Nitroimidazole Antimicrobial class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
6 manufacturers producing TINIDAZOLE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TINDAMAX 500 MG TABLET | $13.0140 per EA | — |
TINDAMAX 500 MG TABLET | $13.0140 per EA | — |
TINIDAZOLE 500 MG TABLET | $2.8431 per EA | — |
TINIDAZOLE 500 MG TABLET | $2.6917 per EA | — |
TINIDAZOLE 250 MG TABLET | $2.3575 per EA | — |
TINIDAZOLE 500 MG TABLET | $2.3543 per EA | +7.08% |
TINIDAZOLE 500 MG TABLET | $2.3543 per EA | +7.08% |
TINIDAZOLE 500 MG TABLET | $2.3543 per EA | +7.08% |
TINIDAZOLE 500 MG TABLET | $2.3543 per EA | +7.08% |
TINIDAZOLE 500 MG TABLET | $2.3543 per EA | +7.08% |
TINIDAZOLE 500 MG TABLET | $2.3353 per EA | — |
TINIDAZOLE 250 MG TABLET | $1.5032 per EA | -4.61% |
TINIDAZOLE 250 MG TABLET | $1.5032 per EA | -4.61% |
TINIDAZOLE 250 MG TABLET | $1.5032 per EA | -4.61% |
Frequently Asked Questions
What is Tinidazole used to treat?
Tinidazole is used to treat amebiasis, giardiasis and bacterial vaginosis, per the National Library of Medicine's MED-RT classification.
When did Tinidazole become available as a generic?
FDA approved the first generic Tinidazole (ANDA) on Apr 30, 2012. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Tinidazole?
In 2024, Medicare Part D spent $387K on Tinidazole across 9,278 claims for 7,323 beneficiaries.
How many Tinidazole products are on the market?
The Tinidazole drug market contains 14 NDCs from 6 manufacturers — 12 generic and 2 brand products.
What is the price range for Tinidazole?
NADAC reference prices for Tinidazole range from $1.5032 to $13.0140 per EA — the most expensive product costs about 8.7× the cheapest.
Is generic Tinidazole cheaper than brand?
The average generic NADAC for Tinidazole is $2.2091 per EA, versus $13.0140 for brand-labeled products — brand versions average about 5.9× the generic price.
Which manufacturers make Tinidazole?
6 manufacturers list Tinidazole in NADAC. Ranked by number of NDCs, the largest are Lupin Pharmaceuticals Inc. (3), Edenbridge Pharmaceuticals LLC (3), Mission Pharmacal Company (2), Rising Pharma Holdings Inc. (2), BioComp Pharma Inc. (2).
How has the price of Tinidazole changed recently?
Over the past 7 days, 5 Tinidazole NDCs rose and 3 fell, with a market-wide average change of +2.7%.